Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Haploidentical Donor Hematopoietic Cell Transplantation for Patients With Severe Aplastic Anemia

NCT04558736 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.

NCT NCT04558736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04558736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Haploidentical Donor Hematopoietic Cell Transplantation for Patients With Severe Aplastic Anemia
Lead sponsor
St. Jude Children's Research Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
January 21, 2021
Completion date
July 1, 2030
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anemia, bone marrow failure syndrome